Hemispherx Biopharma Announces First Large Ampligen Shipment to a Clinical Site Pharmaceutical Investing
Melinta Therapeutics Announces Commitment for New Credit Facility of Up to $135 Million Pharmaceutical Investing
Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial Life Science Investing
Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies Life Science Investing
Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants Cannabis Investing News
Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets Life Science Investing
Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018 Life Science Investing
